- Tytuł:
- Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma
- Autorzy:
- Temat:
-
Thymoma
Immunotherapy
Avelumab
Immune-related adverse events
Immunosuppressive therapy
Anti-PD-L1
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282 - Źródło:
- Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
- Opis pliku:
- electronic resource
- Relacje:
- http://link.springer.com/article/10.1186/s40425-019-0723-9; https://doaj.org/toc/2051-1426
- Dostęp URL:
- https://doaj.org/article/b66a3a1a163041f19fe2d792850a4a64  Link otwiera się w nowym oknie
Czasopismo naukowe